Hemodialysis in Hospitalized End Stage Renal Disease Patients at Surin Hospital
Article Sidebar
Main Article Content
Abstract
Background: In patients with end stage renal disease (ESRD), chronic intoxication according to accumulation of uremic toxin could be treated with hemodialysis. Hemodialysis therefore plays the important role to eliminate uremic toxin. Consequently prolong patient's life, decrease malnutrition and improve quality of life. However complications during dialysis should be cautious by physician and practitioner's team to correct the complications promptly in order to prevent mortality during dialysis.
Objective: To investigate the prevalence of hemodialysis in hospitalized ESRD patients at Surin hospital
Study design: Descriptive retrospective study
Method: The Clinical and laboratory Data collected from patient's chart diagnosed with chronic kidney disease (CKD) and admitted in Surin hospital during January 1st to December 31st 2007. Statistical analysis of descriptive data presented in frequency, mean and percentile.
Result: A total of 339 hospitalized patients diagnosed with CKD were studied. Prevalence of ESRD was 55.67%, and 69 patients had indications for dialysis. Patients were male 55.07%. The mean age was 58.9 ± 14.6 years. The two most common causes of underlying kidney disease were diabetes mellitus and hypertension. The mean haematocrit and haemoglobin level were 27.58 ± 8.43 mg/dl and 9.38 ± 2.30 g/dl respectively. The serum albumin was 3.63 ± 0.72 g/dl. Hyponatremia and hyperkalemia were the most electrolyte disturbances found in these patients. The serum calcium-phosphorus product that greater than 55 mgVdl2 was 21.74%. Dialysis was mostly indicated in oliguria (25.51%) and serum creatinine greater than 8 mg/dl (24.32%). The complications during hemodialysis were hypotension (9.76%) and hypertension (9.26 %)
Conclusion: The prevalence of hemodialysis in hospitalized ESRD patients was 20.35%. Two major indications for dialysis were oliguria and serum creatinine greater than 8 mg/dl. The ESRD complications were anemia, malnutrition and electrolyte disturbances. The most complications during hemodialysis were hypotension and hypertension.
Key words: Hemodialysis, End Stage Renal Disease (ESRD), Complications, Indication
Article Details
References
2. National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for chronic kidney disease : evaluatioa classification, and stratification. Kidney disease outcome quality initiative. Am J Kidney Dis 2002;39:51-246.
3. National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis 2003;41:S1- S56
4. Poggio ED. Wang X, Greene T et al. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005;16:459-66.
5. Cockcroft DW, Gault MH. Prediction fo creatinine clearance from serum creatinine. Nephron ; 1976:16:31-41.
6. อาภรณี ไชยาคำ. Chronic Renal Failure. ใน ตำราเภสัชบำบัด : Textbook of Pharmacotherpy. หน้า 339-342. กรุงเทพฯ : เฮลท์ ออทอริตี้ส์, 2546.
7. โศภณ นภาธร. Hemodialysis. กรุงเทพฯ : เท็กซ์ แอนด์ เจอร์นอล ; 2542.
8. Alfrey AC, Chan L. Chronic renal failure : Manifestations and pathogenesis In : Schrier RW, ed. Renal and electrolyte disorders. Boston : Little Brown and Co., 1992.
9. Manley, Harold J and Drayer Debra K et al. Medication-related problem type and appearance rate in ambulatory hemodialysis patients. BMC Nephrol 2003;10(4).
10. Collins AJ, Li S, St Peter WL, et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit levels of 36-39%. J Am Soc Nephrol 2001;12:2465-73.
11. Block GA, Hulbert'Shearon TE, Levin NW et al. "Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients : A national study," Am J Kidney Dis 1998;31:607-17.
12. Derwa A, Peeters P and Vanholder R. Calcium channel blockers in the prevention of end stage renal disease : a review. Acta Clin Belg 2004;59:44-56.
13. The Seventh Report of the Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure. JAMA 2003;289:2560-72.
14. Chittinandana A Chailimpamontree พ, Chaloeiphap P. Prevalence of Chronic Kidney Disease in Thai Adult Population. J Med Assoc Thai 2006;89(2):S112-20.
15. Stevens LA, Coresh J, Greene T et al. Assessing kidney function-measured and estimated glonerular filtration rate. N Engl J Med 2006 ; 354(23):2473-83.
16. The Naional kidney Foundaion. NKF-K/DOQI Clinical practice guidelines for anemia of chronic kidney disease : update 2000. Am J Kidney Dis 2001;37:S182-238.
17. Tonelli M, Wiebe N, Culleton B et al. Chronic Kidney Disease and Mortality Risk : A Systematic Review. J Am Soc Nephrol 2006;31:1-14.
18. Vasavada N and Agarwal R. Role of excess volume in the pathophysiology of hypertension in chronic kidney disease. Kidney Int 2003;64:1772-9.
19. Vecchio LD, Pozzi M, Salvetti A et al Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril. J Nephrol 2004;17:261-9.
20. Volume CI, Farris KB, Kassam R et al. "Pharmaceutical Care Research and Education Project : Patient Outcomes," J Am Pharm Assoc 2001;41(3):411-20.
21. Weiner ED, Tighiouart H, Amin MG et al. Chronic Kidney Disease as a Risk Factor form Cardiovascular Disease and All-Cause Mortality : A Pooled Analysis of Community-Based Studies. J Am Soc Nephrol 2004;15:1307-15.
